136 related articles for article (PubMed ID: 11865628)
1. [Weekly administration of low-dose paclitaxel for advanced or metastatic breast cancer].
Uno Y; Hirano M; Murakami N; Kikuchi T; Nozawa H; Okuda T; Oya J; Kikkawa H
Gan To Kagaku Ryoho; 2002 Feb; 29(2):227-32. PubMed ID: 11865628
[TBL] [Abstract][Full Text] [Related]
2. [Weekly paclitaxel therapy for metastatic breast cancer].
Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K
Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627
[TBL] [Abstract][Full Text] [Related]
3. [Weekly administration of paclitaxel for advanced or metastatic breast cancer--short-course premedications for outpatients].
Kimura M; Koida T; Yanagita Y
Gan To Kagaku Ryoho; 2000 Oct; 27(11):1703-8. PubMed ID: 11057321
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of biweekly paclitaxel therapy in advanced or recurrent breast cancer].
Kuroi K; Tanaka C; Bando H; Saji S; Hayashi K; Toi M
Gan To Kagaku Ryoho; 2002 Jan; 29(1):55-60. PubMed ID: 11816478
[TBL] [Abstract][Full Text] [Related]
5. [Weekly paclitaxel administration in the adjuvant therapy of primary breast cancer].
Takahashi H; Takahashi M; Taguchi K; Sasaki F; Todo S
Gan To Kagaku Ryoho; 2003 May; 30(5):653-9. PubMed ID: 12795097
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of weekly administration of paclitaxel for advanced or recurrent gastric cancer].
Egawa T; Kubota T; Nagashima A; Doi M; Kitano M; Hayashi S; Yoshii H; Saikawa Y; Kitajima M
Gan To Kagaku Ryoho; 2004 Jun; 31(6):877-81. PubMed ID: 15222104
[TBL] [Abstract][Full Text] [Related]
7. Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancer.
Seidman AD; Hudis CA; McCaffrey J; Tong W; Currie V; Moynahan ME; Theodoulou M; Tepler I; Gollub M; Norton L
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-72-S17-76. PubMed ID: 9374099
[TBL] [Abstract][Full Text] [Related]
8. Weekly high-dose paclitaxel in metastatic and locally advanced breast cancer: a preliminary report.
Akerley W; Sikov WM; Cummings F; Safran H; Strenger R; Marchant D
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-87-S17-90. PubMed ID: 9374102
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer.
Kim R; Osaki A; Toge T
Oncol Rep; 2003; 10(1):145-50. PubMed ID: 12469161
[TBL] [Abstract][Full Text] [Related]
10. Multicenter phase II trial of weekly paclitaxel for advanced or metastatic breast cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01).
Sato K; Inoue K; Saito T; Kai T; Mihara H; Okubo K; Koh J; Mochizuki H; Tabei T;
Jpn J Clin Oncol; 2003 Aug; 33(8):371-6. PubMed ID: 14523055
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxel.
Toppmeyer D; Seidman AD; Pollak M; Russell C; Tkaczuk K; Verma S; Overmoyer B; Garg V; Ette E; Harding MW; Demetri GD
Clin Cancer Res; 2002 Mar; 8(3):670-8. PubMed ID: 11895894
[TBL] [Abstract][Full Text] [Related]
12. [Weekly paclitaxel therapy for locoregional lymph node recurrence of estrogen-receptor-negative breast cancer].
Nishimura H; Hamanaka K; Sakai H; Ohno Y; Miyagawa Y; Seki H; Munakata Y
Gan To Kagaku Ryoho; 2004 Apr; 31(4):627-30. PubMed ID: 15114714
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy.
Brenner B; Ilson DH; Minsky BD; Bains MS; Tong W; Gonen M; Kelsen DP
J Clin Oncol; 2004 Jan; 22(1):45-52. PubMed ID: 14701767
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of weekly administration of paclitaxel for advanced and metastatic gastric cancer].
Emoto T; Yoshikawa K; Fujii M; Nezu R; Dousei T; Fujikawa M; Yoshioka Y; Naka Y; Komaki T
Gan To Kagaku Ryoho; 2003 Jun; 30(6):809-15. PubMed ID: 12852348
[TBL] [Abstract][Full Text] [Related]
15. Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer: a preliminary study.
Nishio S; Ota S; Sugiyama T; Matsuo G; Kawagoe H; Kumagai S; Ushijima K; Nishida T; Kamura T
Int J Clin Oncol; 2003 Feb; 8(1):45-8. PubMed ID: 12601542
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
Adamo V; Ferraro G; Pergolizzi S; Sergi C; Laudani A; Settineri N; Alafaci E; Scimone A; Spano F; Spitaleri G
Oral Oncol; 2004 May; 40(5):525-31. PubMed ID: 15006626
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
[TBL] [Abstract][Full Text] [Related]
18. [Weekly paclitaxel infusion in patients with recurrent ovarian cancer--a pilot study].
Kawagoe H; Kawata T; Nishio S; Shimomura T; Fujiyoshi K; Ishimatsu J; Tsunawaki A
Gan To Kagaku Ryoho; 2003 Jan; 30(1):151-4. PubMed ID: 12557722
[TBL] [Abstract][Full Text] [Related]
19. Phase I and pharmacological study of single paclitaxel administered weekly for heavily pre-treated patients with epithelial ovarian cancer.
Takano M; Kikuchi Y; Kita T; Suzuki M; Ohwada M; Yamamoto T; Yamamoto K; Inoue H; Shimizu K
Anticancer Res; 2002; 22(3):1833-8. PubMed ID: 12168878
[TBL] [Abstract][Full Text] [Related]
20. [Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer].
Shimizu T; Iwasa T; Koike S; Nakamura T; Kanai T; Komatsu D
Gan To Kagaku Ryoho; 2003 Jan; 30(1):105-9. PubMed ID: 12557713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]